Bruce Culleton - 03 Dec 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Chief Executive Officer, Director
Signature
/s/ Todd Girolamo, attorney in fact
Issuer symbol
PROK
Transactions as of
03 Dec 2023
Net transactions value
$0
Form type
4
Filing time
05 Dec 2023, 16:04:57 UTC
Previous filing
03 Aug 2023
Next filing
16 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +2,000,000 $0.000000 2,000,000 03 Dec 2023 Class A Ordinary Shares 2,000,000 $1.69 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price is equal to the greater of (i) the thirty day average stock price of the Company's Class A Ordinary Shares on the Nasdaq Stock Market ("Nasdaq") as of the date of grant (the "Grant Date") and (ii) the closing price of the Company's Class A Ordinary Shares on Nasdaq as of the Grant Date.
F2 The option vests 25% on the first anniversary of November 15, 2023 and the remaining 75% vests in substantially equal quarterly installments over the following 36 months on each quarterly anniversary of November 15, 2023, subject to continued employment through each such vesting date.